Etiqueta: stem cell research
-
Texas Woman Travels to Central America for Adult Stem Cell Treatment
Once again, a U.S. citizen is forced to travel overseas for an adult stem cell therapy which was pioneered by U.S. doctors but which is not available in the United States.
-
Aastrom Resumes Clinical Trial Following FDA Clearance
The FDA has lifted a halt that it imposed last month on a Phase II clinical trial conducted by Aastrom Biosciences, following an investigation into the death of a patient which was determined to be unrelated to the treatment.
-
Adult Stem Cell Companies Seen as Profitable Investment
In an article entitled, "Adult Stem Cells are a Promising Market", investment analysts cite the many financial and scientific advantages of adult stem cells over embryonic stem cells.
-
Autism Treated With Adult Stem Cells
A New York woman reports that her ten-year-old autistic daughter has significantly improved after receiving adult stem cell therapy in Germany.
-
Cellular Dynamics and Mount Sinai Sign Licensing Agreement
The Madison, Wisconsin stem cell startup company, Cellular Dynamics, has announced the licensing of cardiovascular cells from New York’s Mount Sinai Medical School.
-
Pluristem Announces Clinical Trial Site, and Receives Patent For Adult Stem Cell Expansion Method
The U.S. Patent and Trademark Office has awarded a patent to Pluristem Therapeutics for the invention of a novel method of expanding hemopoietic stem cells.
-
Adult Stem Cells Attenuate Immune Rejection
Scientists demonstrate that adult stem cells from bone grafts extend cardiac transplant survival through immune modulation.
-
Biomechanical Forces Stimulate Blood Stem Cell Production
Researchers have traced the embryological development of blood stem cells to mechanical forces produced by the early embryological heart.
-
Brain Injuries Targeted for Adult Stem Cell Therapy
Researchers propose adult stem cells derived from adipose tissue as a therapy for traumatic brain injury.
-
Pfizer and the University of Wisconsin Form Licensing Agreement
In yet another merger of Big Pharma and academia, two of the world’s leading research entities join forces for combined stem cell R&D.